-Livemint.com
The interim injunction has been granted till Cipla’s application for compulsory licensing of the drug is decided
New Delhi: The Delhi high court on Friday restrained homegrown generic drug maker Cipla Ltd from making and selling Indacaterol, a drug claimed to be patented by Swiss pharma company Novartis AG.
Indacaterol is a respiratory drug used in the treatment of chronic obstructive pulmonary disease and is sold under the brand name Onbrez.
Please click here to access.